Literature DB >> 21348982

Background, introduction and activity of the Japan Primary Registries Network.

Tomonori Shiokawa1.   

Abstract

Regarding registration and publication of clinical trials, there are now three registry organizations in Japan; the University Hospital Medical Information Network (UMIN), the Japan Pharmaceutical Information Center (JAPIC) and the Japan Medical Association - Center for Clinical Trials (JMACCT). In addition, a portal site which supports searching for information on clinical trials in all three registries has been operated by the National Institute of Public Health (NIPH). After we established a cooperative system, we became a WHO Primary Registry on October 16, 2008 and announced this in Japan on the next day. This cooperation system is called the Japan Primary Registries Network (JPRN). In order to show that this type of network works well as a Primary Registry, we are cooperating with global activities of World Health Organization's International Clinical Trial Registry Platform (WHO ICTRP) to promote clinical trials and propose appropriate idea to the world.
© 2009 Blackwell Publishing Asia Pty Ltd and Chinese Cochrane Center, West China Hospital of Sichuan University.

Mesh:

Year:  2009        PMID: 21348982     DOI: 10.1111/j.1756-5391.2009.01013.x

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  3 in total

1.  Review of the registration of clinical trials in UMIN-CTR from 2 June 2005 to 1 June 2010 - focus on Japan domestic, academic clinical trials.

Authors:  Wentao Tang; Manabu Fukuzawa; Hirono Ishikawa; Kiichiro Tsutani; Takahiro Kiuchi
Journal:  Trials       Date:  2013-10-14       Impact factor: 2.279

2.  Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013.

Authors:  Roderik F Viergever; Keyang Li
Journal:  BMJ Open       Date:  2015-09-25       Impact factor: 2.692

3.  Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.

Authors:  Tatsuya Ito
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.